Hyperfine (HYPR) Change in Account Payables (2021 - 2026)
Hyperfine (HYPR) reported Change in Account Payables of $6000.0 for Q1 2026, down 99.0% on a YoY basis from $600000.0 in Q1 2025, and up 20.0% quarter-over-quarter from $5000.0 in Q4 2025.
Hyperfine (HYPR) Change in Account Payables (2021 - 2026) Analysis & Trends
Hyperfine has reported Change in Account Payables for 6 years, with the latest figure at $6000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 99.0% year-over-year to $6000.0; the trailing twelve-month figure through Mar 2026 stood at -$605000.0 (down 160.62% YoY), and the FY2025 full-year result was -$11000.0, down 102.88% from the prior year.
- Change in Account Payables for Q1 2026 stood at $6000.0, up from $5000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $1.3 million in Q2 2022, with the low at -$1.9 million in Q1 2022.
- Historically, Change in Account Payables has averaged -$66588.2 across 5 years, with a median of -$14000.0 in 2025.
- Annual changes were most pronounced in 2022 — Change in Account Payables slumped 10015.79% — and 2025, when it soared 3850.0%.
- Hyperfine's Change in Account Payables stood at -$48000.0 in 2022, then tumbled by 250.0% to -$168000.0 in 2023, then soared by 332.14% to $390000.0 in 2024, then sank by 98.72% to $5000.0 in 2025, then rose by 20.0% to $6000.0 in 2026.
- The last three Change in Account Payables figures came in at $6000.0 (Q1 2026), $5000.0 (Q4 2025), and -$14000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Hyperfine | 155.82 Mn | 114.55 Mn | 1.98 Mn | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | -14,000.00 |
| Sep 30, 2025 | -14,000.00 |
| Jun 30, 2025 | -602,000.00 |
| Jun 30, 2025 | -602,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 390,000.00 |
| Dec 31, 2024 | 390,000.00 |
| Sep 30, 2024 | -875,000.00 |
| Sep 30, 2024 | -875,000.00 |
| Jun 30, 2024 | 883,000.00 |
| Jun 30, 2024 | 883,000.00 |
| Mar 31, 2024 | -16,000.00 |
| Mar 31, 2024 | -16,000.00 |
| Dec 31, 2023 | -168,000.00 |
| Dec 31, 2023 | -168,000.00 |